RPAM
IMCR icon

Rhenman & Partners Asset Management’s Immunocore IMCR Stock Holding History

Rhenman & Partners Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-85,724
Closed -$2.58M – 104
2026
Q1 		$2.58M Sell
85,724
-67,554
-44% -$2.19M 0.32% 75
2025
Q4 		$5.32M Buy
153,278
+125,000
+442% +$4.41M 0.5% 62
2025
Q3 		$1.03M Hold
28,278
– – 0.11% 90
2025
Q2 		$887K Hold
28,278
– – 0.11% 88
2025
Q1 		$839K Sell
28,278
-30,000
-51% -$900K 0.1% 88
2024
Q4 		$1.72M Hold
58,278
– – 0.18% 83
2024
Q3 		$1.81M Hold
58,278
– – 0.15% 87
2024
Q2 		$1.98M Sell
58,278
-21,500
-27% -$1.1M 0.19% 77
2024
Q1 		$5.19M Sell
79,778
-4,500
-5% -$309K 0.49% 53
2023
Q4 		$5.76M Sell
84,278
-5,000
-6% -$260K 0.58% 56
2023
Q3 		$4.63M Hold
89,278
– – 0.5% 51
2023
Q2 		$5.35M Sell
89,278
-42,010
-32% -$2.4M 0.56% 55
2023
Q1 		$6.24M Sell
131,288
-18,712
-12% -$1.05M 0.68% 49
2022
Q4 		$8.56M Hold
150,000
– – 0.89% 41
2022
Q3 		$8.57M Buy
150,000
+10,000
+7% +$477K 0.9% 44
2022
Q2 		$5.22M Sell
140,000
-30,472
-18% -$990K 0.59% 52
2022
Q1 		$5.1M Buy
170,472
+80,472
+89% +$2.03M 0.5% 61
2021
Q4 		$3.07M Hold
90,000
– – 0.2% 83
2021
Q3 		$3.34M Hold
90,000
– – 0.23% 84
2021
Q2 		$3.52M Buy
+90,000
New +$3.47M 0.24% 85

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Rhenman & Partners Asset Management's IMCR Position: Q2 2026 in Review

Rhenman & Partners Asset Management sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 85,724 shares — an estimated $2.58M sold.

Rhenman & Partners Asset Management first reported a position in IMCR in Q2 2021 and held it in 20 quarters. The position peaked at $8.57M in Q3 2022. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Rhenman & Partners Asset Management reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 85,724 Immunocore shares in Q2 2026, an estimated $2.58M.
  • Rhenman & Partners Asset Management first reported a position in Immunocore in Q2 2021 and held it in 20 quarters.
  • Rhenman & Partners Asset Management's Immunocore position peaked at $8.57M in Q3 2022.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.